NCT03495557 (PSHERNIA) is a Phase 4 clinical trial of Control in Incisional Hernia, sponsored by Hospital de Mataró.

Who is sponsoring NCT03495557?

NCT03495557 is sponsored by Hospital de Mataró.

What drugs are being tested in NCT03495557?

Interventions in NCT03495557: Control, Experimental.

What condition does NCT03495557 study?

NCT03495557 studies Incisional Hernia.

Is NCT03495557 still recruiting?

NCT03495557 is currently completed. Last updated 23 March 2022.

Last reviewed 2022-03-23 · How we verify

NCT03495557: PSHERNIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Port Site Hernia After Mesh Placement in Laparoscopic Cholecystectomy.

Completed Phase 4 Last updated 23 March 2022

What this trial tests

Phase 4 trial testing Control in Incisional Hernia in 200 participants. Completed in 1 September 2021.

Timeline

1 January 2018

Primary endpoint
1 December 2020

1 September 2021

Quick facts

Lead sponsor	Hospital de Mataró
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	200
Start date	1 January 2018
Primary completion	1 December 2020
Estimated completion	1 September 2021
Sites	1 location across Spain

Drugs / interventions tested

Control
Experimental — full drug profile →

Conditions studied

Incisional Hernia — all drugs for Incisional Hernia →

Sponsor

Hospital de Mataró

Who can join

18 and older, any sex, with Incisional Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prophylactic mesh fixation after fascial closure in umbilical trocar after cholecystectomy may prevent the trocar site hernia incidence. Especially in patients who present certain risk factors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessment of the effectiveness of a polypropylene onlay mesh in the prevention of laparoscopic trocar-site incisional hernia in high-risk patients. A randomized clinical trial.
Ciscar A, Sánchez-Sáez E, Vila Tura M, Ruiz de Leon P, et al · · 2024 · cited 2× · PMID 39207550 · DOI 10.1007/s10029-024-03124-7

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting

Other recruiting trials for Incisional Hernia

Currently open trials in the same condition.

NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting
NCT06499324 — Surgery with Botulinum Toxin a for Incisional Hernia · Phase 3 · recruiting
NCT06220058 — Comparing Polypropylene Mesh and "Small Bites" Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. S · NA · recruiting
NCT05596357 — Incisional heRnia dIgestion Sexuality · recruiting

Other Hospital de Mataró trials

Trials by the same sponsor.

NCT07192328 — Dose-Efficacy of rTMS in Healthy Young Female Volunteers · NA · completed
NCT06217211 — Eficacia Ventilatoria y Remolacha · NA · unknown
NCT06250426 — Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia · NA · unknown
NCT05958173 — Effects of 6-month of Treatment With TRPV1 and TRPA1 Agonists in Older Patients With OD · NA · unknown
NCT04739891 — Acute Cholecystitis With Concomitant Choledocholithiasis: Unicentric Study of Prevalence and Predictive Factors · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03495557 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital de Mataró
Last refreshed: 23 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03495557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing